Little Green Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Little Green Pharma has a total shareholder equity of A$77.3M and total debt of A$3.5M, which brings its debt-to-equity ratio to 4.5%. Its total assets and total liabilities are A$86.3M and A$9.0M respectively.
Key information
4.5%
Debt to equity ratio
AU$3.50m
Debt
| Interest coverage ratio | n/a |
| Cash | AU$4.97m |
| Equity | AU$77.26m |
| Total liabilities | AU$9.03m |
| Total assets | AU$86.29m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LGP's short term assets (A$21.5M) exceed its short term liabilities (A$6.4M).
Long Term Liabilities: LGP's short term assets (A$21.5M) exceed its long term liabilities (A$2.6M).
Debt to Equity History and Analysis
Debt Level: LGP has more cash than its total debt.
Reducing Debt: LGP had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LGP has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if LGP has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.